title: Passenger B-lymphocyte-induced severe hemolytic disease after allogeneic peripheral blood stem cell transplantation.
authors.forename: A
authors.initials: A
authors.lastname: Toren
authors.forename: Y
authors.initials: Y
authors.lastname: Dacosta
authors.forename: N
authors.initials: N
authors.lastname: Manny
authors.forename: G
authors.initials: G
authors.lastname: Varadi
authors.forename: R
authors.initials: R
authors.lastname: Or
authors.forename: A
authors.initials: A
authors.lastname: Nagler
mesh_terms: D000017:ABO Blood-Group System / Q000276:immunology*; D000743:Anemia, Hemolytic / Q000209:etiology* / Q000628:therapy; D001402:B-Lymphocytes / Q000276:immunology / Q000637:transplantation*; D001787:Blood Group Incompatibility / Q000150:complications*; D002648:Child; D003131:Combined Modality Therapy; D004912:Erythrocytes / Q000276:immunology; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008776:Methylprednisolone Hemisuccinate / Q000627:therapeutic use; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy
chemical_list: D000017:ABO Blood-Group System; D005938:Glucocorticoids; D008776:Methylprednisolone Hemisuccinate